• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人卵巢癌在裸鼠体内的腹腔和皮下异种移植及其在实验治疗中的潜力。

Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy.

作者信息

Massazza G, Tomasoni A, Lucchini V, Allavena P, Erba E, Colombo N, Mantovani A, D'Incalci M, Mangioni C, Giavazzi R

机构信息

Mario Negri Institute for Pharmacological Research, Bergamo.

出版信息

Int J Cancer. 1989 Sep 15;44(3):494-500. doi: 10.1002/ijc.2910440320.

DOI:10.1002/ijc.2910440320
PMID:2777413
Abstract

Human ovarian carcinomas (HOC) were established s.c. and i.p. in nude mice and the biological characteristics were investigated for 4 xenografts. HOC8 and HOC18, derived respectively from a primary tumor of the ovary and a pleural effusion (from 2 different patients) were established s.c. in nude mice. HOC10 and HOC22, derived from the ascites of 2 patients, were directly established as ascites after i.p. injection in nude mice. The s.c. and i.p. growth behavior of the 4 HOC lines was investigated. HOC18, HOC8 and HOC22 cells produced progressively growing tumor after s.c. injection but HOC10 ascites would not grow s.c. The cell suspension derived from HOC18 only produced carcinomatosis upon i.p. injection, while HOC8 cells produced both ascites and carcinomatosis. The 2 ascites HOC10 and HOC22 produced ascites in nude mice, but only HOC22 formed i.p. carcinomatosis. Histopathological characteristics of the patients' primary tumors persisted in nude mice, regardless of the site of tumor implantation. DNA histograms of the xenografts closely matched the patients' tumors and remained stable at different passages. Cisplatin, adriamycin and cyclophosphamide given i.v. were tested against HOC8 and HOC18 growing s.c. and HOC22 and HOC10 growing i.p. HOC8 showed a significant response to DDP and almost no sensitivity to ADR and CTX. HOC18 showed only moderate growth delay with all 3 drugs. Mice bearing HOC10 and HOC22 ascites had a prolonged survival time after DDP and ADR treatment.

摘要

人卵巢癌(HOC)在裸鼠体内皮下和腹腔接种建立模型,并对4种异种移植瘤的生物学特性进行了研究。分别源自卵巢原发性肿瘤和胸腔积液(来自2名不同患者)的HOC8和HOC18在裸鼠体内皮下接种建立模型。源自2名患者腹水的HOC10和HOC22在裸鼠腹腔注射后直接建立腹水模型。研究了4种HOC细胞系的皮下和腹腔生长行为。皮下注射后,HOC18、HOC8和HOC22细胞产生逐渐生长的肿瘤,但HOC10腹水不能在皮下生长。源自HOC18的细胞悬液腹腔注射后仅产生癌转移,而HOC8细胞则产生腹水和癌转移。两种腹水型HOC10和HOC22在裸鼠体内产生腹水,但只有HOC22形成腹腔癌转移。患者原发性肿瘤的组织病理学特征在裸鼠体内持续存在,与肿瘤植入部位无关。异种移植瘤的DNA直方图与患者肿瘤密切匹配,且在不同传代时保持稳定。对皮下生长的HOC8和HOC18以及腹腔生长的HOC22和HOC10进行了静脉注射顺铂、阿霉素和环磷酰胺的测试。HOC8对顺铂有显著反应,对阿霉素和环磷酰胺几乎不敏感。HOC18对所有3种药物仅表现出中度生长延迟。携带HOC10和HOC22腹水的小鼠在顺铂和阿霉素治疗后存活时间延长。

相似文献

1
Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy.人卵巢癌在裸鼠体内的腹腔和皮下异种移植及其在实验治疗中的潜力。
Int J Cancer. 1989 Sep 15;44(3):494-500. doi: 10.1002/ijc.2910440320.
2
Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts.埃博霉素-743,一种对人卵巢癌异种移植瘤具有强大抗肿瘤活性的新型海洋天然产物。
Clin Cancer Res. 1998 Aug;4(8):1977-83.
3
Malignant behavior and resistance to cisplatin of human ovarian carcinoma xenografts established from the same patient at different stages of the disease.从同一患者疾病不同阶段建立的人卵巢癌异种移植瘤的恶性行为及对顺铂的耐药性。
Cancer Res. 1991 Dec 1;51(23 Pt 1):6358-62.
4
Comparison of paclitaxel and docetaxel activity on human ovarian carcinoma xenografts.
Eur J Cancer. 1994;30A(5):691-6. doi: 10.1016/0959-8049(94)90547-9.
5
Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.batimastat是一种基质金属蛋白酶的合成抑制剂,可增强顺铂在卵巢癌异种移植模型中的抗肿瘤活性。
Clin Cancer Res. 1998 Apr;4(4):985-92.
6
Antitumor activity of taxol (NSC-125973) in human ovarian carcinomas growing in the peritoneal cavity of nude mice.紫杉醇(NSC - 125973)对裸鼠腹腔内生长的人卵巢癌的抗肿瘤活性。
Ann Oncol. 1993 Feb;4(2):151-5. doi: 10.1093/oxfordjournals.annonc.a058419.
7
The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.酪氨酸激酶受体抑制剂SU6668与紫杉醇联合使用可影响原位生长的卵巢癌异种移植瘤的腹水形成和肿瘤扩散。
Clin Cancer Res. 2003 Aug 15;9(9):3476-85.
8
Tumour levels of O6-alkylguanine-DNA-alkyltransferase and sensitivity to BCNU of human xenografts.人异种移植瘤中O6-烷基鸟嘌呤-DNA烷基转移酶的肿瘤水平及对卡氮芥的敏感性
Anticancer Res. 1992 Nov-Dec;12(6B):2123-5.
9
Biological and pharmacological characterisation of three models of human ovarian carcinoma established in nude mice: use of the CA125 tumour marker to predict antitumour activity.在裸鼠中建立的三种人卵巢癌模型的生物学和药理学特性:使用CA125肿瘤标志物预测抗肿瘤活性。
Int J Oncol. 1999 Dec;15(6):1155-62. doi: 10.3892/ijo.15.6.1155.
10
Effects of tumour necrosis factor on human tumour xenografts in nude mice.肿瘤坏死因子对裸鼠人肿瘤异种移植的影响。
Ciba Found Symp. 1987;131:154-69. doi: 10.1002/9780470513521.ch11.

引用本文的文献

1
Harnessing preclinical models for the interrogation of ovarian cancer.利用临床前模型探究卵巢癌。
J Exp Clin Cancer Res. 2022 Sep 16;41(1):277. doi: 10.1186/s13046-022-02486-z.
2
Integrated molecular profiling of patient-derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities.对患者来源的卵巢癌模型进行综合分子分析,确定具有临床相关性的特征和肿瘤易损性。
Int J Cancer. 2022 Jul 15;151(2):240-254. doi: 10.1002/ijc.33983. Epub 2022 Mar 14.
3
Establishment of patient-derived tumor xenograft models of mucinous ovarian cancer.
黏液性卵巢癌患者来源的肿瘤异种移植模型的建立。
Am J Cancer Res. 2020 Feb 1;10(2):572-580. eCollection 2020.
4
Establishment of an insufficient radiofrequency ablation orthotopic nude mouse model of hepatocellular carcinoma to study the invasiveness and metastatic potential of residual cancer.建立肝癌射频消融不足原位裸鼠模型以研究残余癌的侵袭性和转移潜能。
Oncol Lett. 2019 Sep;18(3):2548-2553. doi: 10.3892/ol.2019.10552. Epub 2019 Jul 2.
5
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models.在临床前模型中,鲁比卡丁可减少肿瘤相关巨噬细胞和炎性肿瘤微环境。
Br J Cancer. 2017 Aug 22;117(5):628-638. doi: 10.1038/bjc.2017.205. Epub 2017 Jul 6.
6
Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma.高级别浆液性卵巢癌患者来源异种移植瘤的组织学和分子分析
J Hematol Oncol. 2016 Sep 21;9(1):92. doi: 10.1186/s13045-016-0318-6.
7
Establishment and characterization of intraperitoneal xenograft models by co-injection of human tumor cells and extracellular matrix gel.通过共注射人肿瘤细胞和细胞外基质凝胶建立并表征腹腔内异种移植模型。
Oncol Lett. 2015 Dec;10(6):3450-3456. doi: 10.3892/ol.2015.3764. Epub 2015 Sep 29.
8
Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin.西地尼布联合化疗可减少肿瘤播散,并延长携带对顺铂有不同反应的患者来源的卵巢癌异种移植瘤小鼠的生存期。
Clin Exp Metastasis. 2015 Oct;32(7):647-58. doi: 10.1007/s10585-015-9734-1. Epub 2015 Jul 17.
9
The promise and challenge of ovarian cancer models.卵巢癌模型的前景与挑战。
Transl Cancer Res. 2015 Feb;4(1):14-28. doi: 10.3978/j.issn.2218-676X.2015.01.02.
10
Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.高级别浆液性卵巢癌的肿瘤筛查、成像及虚拟替身技术进展
Front Oncol. 2014 Nov 18;4:322. doi: 10.3389/fonc.2014.00322. eCollection 2014.